SARAH GOLDEN: Open Payments
NPI 1912649005 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 32 payments from 12 companies in 2025. Trend: 2023 $1,817 · 2024 $1,156 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $188 |
| Neurocrine BioSciences, Inc. | 3 | $89 |
| Alkermes, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Bausch Health US, LLC | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| Indivior Inc. | 1 | $27 |
| Noven Therapeutics, LLC | 1 | $24 |
| Corium, LLC | 1 | $23 |
Products named: VRAYLAR, INGREZZA, REXULTI, APLENZIN, SPRAVATO, ARISTADA, SUBLOCADE, UZEDY.
Industry payments across TN — which companies pay providers there.
